https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(22)00222-3/fulltext
0
0
8/26/22 at 2:28am
Organization
The Lancet
Authors
We read the Comment by Amit Saxena and colleagues1 regarding the clinical efficacy
and seroreactivity of an additional COVID-19 vaccine dose in patients with systemic
lupus erythematosus with great interest.1 Samples were analysed at a mean of 44·7
days (SD 3…
Create an account
or login to join the discussion